 |
 Video: What is a Stock Split?
|
|
|
| Kaleido Biosciences is a clinical-stage healthcare company with an approach focused on utilizing the microbiome to treat disease and improve human health. Co.'s product candidates are Microbiome Metabolic Therapies (MMTs), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and composition of the existing microbes. Co. has an approach to the discovery and development of MMTs, and its initial MMTs are targeted glycans. Each targeted glycan is an ensemble of complex carbohydrates that is intended to modulate microbial metabolism and community composition to drive a specific biological response. According to our Kaleido Biosciences stock split history records, Kaleido Biosciences has had 0 splits. | |
|
Kaleido Biosciences (KLDO) has 0 splits in our Kaleido Biosciences stock split history database.
Looking at the Kaleido Biosciences stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Kaleido Biosciences shares, starting with a $10,000 purchase of KLDO, presented on a split-history-adjusted basis factoring in the complete Kaleido Biosciences stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/01/2019 |
|
| End date: |
02/14/2023 |
|
| Start price/share: |
$14.77 |
|
| End price/share: |
$0.01 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.93% |
|
| Average Annual Total Return: |
-84.15% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$6.77 |
|
| Years: |
3.96 |
|
|
|
|
|
